Global Addison's Disease Therapeutics Market 2023-2027

Global Addison's Disease Therapeutics Market 2023-2027

Technavio has been monitoring Addison's disease therapeutics market and is poised to grow by $442 mn from 2023-2027, accelerating at a CAGR of 6.93% during the forecast period. Our report on Addison's disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by special drug designations, reformulation of drugs, and favorable reimbursement scenarios.

Technavio's Addison's disease therapeutics market is segmented as below:

By Therapy

  • Oral drugs
  • Parenteral drugs
By End-user
  • Hospitals
  • clinics
  • Diagnostic laboratories
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the expanding research into the development of regenerative therapy as one of the prime reasons driving Addison's disease therapeutics market growth during the next few years. Also, the availability of clinical guidelines and redefined pathophysiology will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on Addison's disease therapeutics market covers the following areas:
  • Addison's disease therapeutics market sizing
  • Addison's disease therapeutics market forecast
  • Addison's disease therapeutics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Addison's disease therapeutics market vendors that include Actiza Pharmaceutical Pvt. Ltd., Akorn Operating Co. LLC, Amneal Pharmaceuticals Inc., Bristol Myers Squibb Co., Neurocrine Biosciences Inc., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., GlaxoSmithKline Plc, Abbott Laboratories, Amgen Inc., Eli Lilly and Co., Biogen Inc., Boehringer Ingelheim International GmbH, Bio Techne Corp., Lupin Ltd., BTL Biotechno Labs Pvt. Ltd., and Bayer AG. Also, Addison's disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market through the study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


  • Executive Summary
    • Market overview
      • Table Executive Summary – Chart on Market Overview
      • Table Executive Summary – Data Table on Market Overview
      • Table Executive Summary – Chart on Global Market Characteristics
      • Table Executive Summary – Chart on Market by Geography
      • Table Executive Summary – Chart on Market Segmentation by Therapy
      • Table Executive Summary – Chart on Market Segmentation by End-user
      • Table Executive Summary – Chart on Incremental Growth
      • Table Executive Summary – Data Table on Incremental Growth
      • Table Executive Summary – Chart on Vendor Market Positioning
  • Market Landscape
    • Market ecosystem
      • Table Parent market
      • Table Market Characteristics
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2022
    • Market outlook: Forecast for 2022-2027
      • Table Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Table Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Table Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Historic Market Size
    • Global addisons disease therapeutics market 2017 - 2021
      • Table Historic market size – Data table on global addisons disease therapeutics market 2017 - 2021 ($ million)
    • Therapy Segment Analysis 2017 - 2021
      • Table Historic market size – Therapy segment 2017 - 2021 ($ million)
    • End-user Segment Analysis 2017 - 2021
      • Table Historic market size – End-user segment 2017 - 2021 ($ million)
    • Geography Segment Analysis 2017 - 2021
      • Table Historic market size – Geography segment 2017 - 2021 ($ million)
    • Country Segment Analysis 2017 - 2021
      • Table Historic market size – Country segment 2017 - 2021 ($ million)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis - Comparison between 2022 and 2027
    • Bargaining power of buyers
      • Table Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • Threat of new entrants
      • Table Threat of new entrants – Impact of key factors in 2022 and 2027
    • Threat of substitutes
      • Table Threat of substitutes – Impact of key factors in 2022 and 2027
    • Threat of rivalry
      • Table Threat of rivalry – Impact of key factors in 2022 and 2027
    • Market condition
      • Table Chart on Market condition - Five forces 2022 and 2027
  • Market Segmentation by Therapy
    • Market segments
      • Table Chart on Therapy - Market share 2022-2027 (%)
      • Table Data Table on Therapy - Market share 2022-2027 (%)
    • Comparison by Therapy
      • Table Chart on Comparison by Therapy
      • Table Data Table on Comparison by Therapy
    • Oral drugs - Market size and forecast 2022-2027
      • Table Chart on Oral drugs - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on Oral drugs - Market size and forecast 2022-2027 ($ million)
      • Table Chart on Oral drugs - Year-over-year growth 2022-2027 (%)
      • Table Data Table on Oral drugs - Year-over-year growth 2022-2027 (%)
    • Parenteral drugs - Market size and forecast 2022-2027
      • Table Chart on Parenteral drugs - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on Parenteral drugs - Market size and forecast 2022-2027 ($ million)
      • Table Chart on Parenteral drugs - Year-over-year growth 2022-2027 (%)
      • Table Data Table on Parenteral drugs - Year-over-year growth 2022-2027 (%)
    • Market opportunity by Therapy
      • Table Market opportunity by Therapy ($ million)
  • Market Segmentation by End-user
    • Market segments
      • Table Chart on End-user - Market share 2022-2027 (%)
      • Table Data Table on End-user - Market share 2022-2027 (%)
    • Comparison by End-user
      • Table Chart on Comparison by End-user
      • Table Data Table on Comparison by End-user
    • Hospitals and clinics - Market size and forecast 2022- 2027
      • Table Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Table Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
      • Table Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
    • Diagnostic laboratories - Market size and forecast 2022- 2027
      • Table Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
      • Table Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
      • Table Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
    • Market opportunity by End-user
      • Table Market opportunity by End-user ($ million)
  • Customer Landscape
    • Customer landscape overview
      • Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Geographic Landscape
    • Geographic segmentation
      • Table Chart on Market share by geography 2022-2027 (%)
      • Table Data Table on Market share by geography 2022-2027 (%)
    • Geographic comparison
      • Table Chart on Geographic comparison
      • Table Data Table on Geographic comparison
    • North America - Market size and forecast 2022-2027
      • Table Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Table Chart on North America - Year-over-year growth 2022-2027 (%)
      • Table Data Table on North America - Year-over-year growth 2022-2027 (%)
    • Europe - Market size and forecast 2022-2027
      • Table Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Table Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Table Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • Asia - Market size and forecast 2022-2027
      • Table Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Table Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Table Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • Rest of World (ROW) - Market size and forecast 2022- 2027
      • Table Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Table Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Table Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • US - Market size and forecast 2022-2027
      • Table Chart on US - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Table Chart on US - Year-over-year growth 2022-2027 (%)
      • Table Data Table on US - Year-over-year growth 2022-2027 (%)
    • Germany - Market size and forecast 2022-2027
      • Table Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Table Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Table Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • UK - Market size and forecast 2022-2027
      • Table Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Table Chart on UK - Year-over-year growth 2022-2027 (%)
      • Table Data Table on UK - Year-over-year growth 2022-2027 (%)
    • Japan - Market size and forecast 2022-2027
      • Table Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Table Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Table Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • Canada - Market size and forecast 2022-2027
      • Table Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Table Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Table Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Table Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Market drivers
      • Special drug designations
      • Reformulation of drugs
      • Favourable reimbursement scenario
    • Market challenges
      • Delayed diagnosis
      • Adverse effects associated with available drugs
      • Limited patient pool
    • Impact of drivers and challenges
      • Table Impact of drivers and challenges in 2022 and 2027
    • Market trends
      • Expanding research into development of regenerative therapy
      • Availability of clinical guidelines
      • Redefined pathophysiology
  • Vendor Landscape
    • Overview
    • Vendor landscape
      • Table Overview on Criticality of inputs and Factors of differentiation
    • Landscape disruption
      • Table Overview on factors of disruption
    • Industry risks
      • Table Impact of key risks on business
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Matrix on vendor position and classification
    • Abbott Laboratories
      • Table Abbott Laboratories - Overview
      • Table Abbott Laboratories - Business segments
      • Table Abbott Laboratories - Key news
      • Table Abbott Laboratories - Key offerings
      • Table Abbott Laboratories - Segment focus
    • Actiza Pharmaceutical Pvt. Ltd.
      • Table Actiza Pharmaceutical Pvt. Ltd. - Overview
      • Table Actiza Pharmaceutical Pvt. Ltd. - Product / Service
      • Table Actiza Pharmaceutical Pvt. Ltd. - Key offerings
    • Akorn Operating Co. LLC
      • Table Akorn Operating Co. LLC - Overview
      • Table Akorn Operating Co. LLC - Product / Service
      • Table Akorn Operating Co. LLC - Key offerings
    • Amgen Inc.
      • Table Amgen Inc. - Overview
      • Table Amgen Inc. - Product / Service
      • Table Amgen Inc. - Key offerings
    • Amneal Pharmaceuticals Inc.
      • Table Amneal Pharmaceuticals Inc. - Overview
      • Table Amneal Pharmaceuticals Inc. - Business segments
      • Table Amneal Pharmaceuticals Inc. - Key news
      • Table Amneal Pharmaceuticals Inc. - Key offerings
      • Table Amneal Pharmaceuticals Inc. - Segment focus
    • Bayer AG
      • Table Bayer AG - Overview
      • Table Bayer AG - Business segments
      • Table Bayer AG - Key offerings
      • Table Bayer AG - Segment focus
    • Bristol Myers Squibb Co.
      • Table Bristol Myers Squibb Co. - Overview
      • Table Bristol Myers Squibb Co. - Product / Service
      • Table Bristol Myers Squibb Co. - Key offerings
    • Eli Lilly and Co.
      • Table Eli Lilly and Co. - Overview
      • Table Eli Lilly and Co. - Product / Service
      • Table Eli Lilly and Co. - Key offerings
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Segment focus
    • Hikma Pharmaceuticals Plc
      • Table Hikma Pharmaceuticals Plc - Overview
      • Table Hikma Pharmaceuticals Plc - Business segments
      • Table Hikma Pharmaceuticals Plc - Key offerings
      • Table Hikma Pharmaceuticals Plc - Segment focus
    • Merck and Co. Inc.
      • Table Merck and Co. Inc. - Overview
      • Table Merck and Co. Inc. - Business segments
      • Table Merck and Co. Inc. - Key news
      • Table Merck and Co. Inc. - Key offerings
      • Table Merck and Co. Inc. - Segment focus
    • Neurocrine Biosciences Inc.
      • Table Neurocrine Biosciences Inc. - Overview
      • Table Neurocrine Biosciences Inc. - Product / Service
      • Table Neurocrine Biosciences Inc. - Key offerings
    • Novartis AG
      • Table Novartis AG - Overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Segment focus
    • Pfizer Inc.
      • Table Pfizer Inc. - Overview
      • Table Pfizer Inc. - Product / Service
      • Table Pfizer Inc. - Key news
      • Table Pfizer Inc. - Key offerings
    • Takeda Pharmaceutical Co. Ltd.
      • Table Takeda Pharmaceutical Co. Ltd. - Overview
      • Table Takeda Pharmaceutical Co. Ltd. - Product / Service
      • Table Takeda Pharmaceutical Co. Ltd. - Key news
      • Table Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Inclusions and exclusions checklist
      • Table Inclusions checklist
      • Table Exclusions checklist
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings